15/07/2026
HSCL 🔥🔥
Revenue 1433 cr VS 1128 cr
( + 26.91% Y-0-Y | + 11.19%Q-0-Q)
PAT 228 CR vs 179 Cr
( + 27%Y-0-Y | + 10.30% Q-0-Q)
EBITDA margin 20.25% VS 19.43
✅ CAPEX update 🧐
Announced 368 cr of new growth Capex
70cr +128 cr +170 cr ( carbon black Capex)
128Cr expansion of Anthraqunione & Carbzole capacity from 2600 MTPA to 5600 MTPA